- Home
- MLAB vs MGTX Comparison
MLAB vs MGTX Comparison
Compare MLAB & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLAB
- MGTX
- Stock Information
- Founded
- MLAB 1982
- MGTX 2015
- Country
- MLAB United States
- MGTX United States
- Employees
- MLAB N/A
- MGTX N/A
- Industry
- MLAB Industrial Machinery/Components
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MLAB Industrials
- MGTX Health Care
- Exchange
- MLAB Nasdaq
- MGTX Nasdaq
- Market Cap
- MLAB 524.2M
- MGTX 520.8M
- IPO Year
- MLAB N/A
- MGTX N/A
- Fundamental
- Price
- MLAB $95.82
- MGTX $6.34
- Analyst Decision
- MLAB Hold
- MGTX Strong Buy
- Analyst Count
- MLAB 2
- MGTX 2
- Target Price
- MLAB $130.00
- MGTX $24.00
- AVG Volume (30 Days)
- MLAB 126.1K
- MGTX 451.7K
- Earning Date
- MLAB 08-04-2025
- MGTX 08-11-2025
- Dividend Yield
- MLAB 0.67%
- MGTX N/A
- EPS Growth
- MLAB N/A
- MGTX N/A
- EPS
- MLAB N/A
- MGTX N/A
- Revenue
- MLAB $240,978,000.00
- MGTX $34,508,000.00
- Revenue This Year
- MLAB $6.28
- MGTX $365.04
- Revenue Next Year
- MLAB $5.93
- MGTX $73.18
- P/E Ratio
- MLAB N/A
- MGTX N/A
- Revenue Growth
- MLAB 11.47
- MGTX 203.23
- 52 Week Low
- MLAB $83.68
- MGTX $3.85
- 52 Week High
- MLAB $155.12
- MGTX $8.75
- Technical
- Relative Strength Index (RSI)
- MLAB 36.61
- MGTX 55.84
- Support Level
- MLAB $87.80
- MGTX $6.21
- Resistance Level
- MLAB $105.59
- MGTX $6.76
- Average True Range (ATR)
- MLAB 4.00
- MGTX 0.39
- MACD
- MLAB -0.44
- MGTX 0.08
- Stochastic Oscillator
- MLAB 43.12
- MGTX 63.40
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.